The F.D.A. approved Merck’s injected version of its blockbuster infusion Keytruda. The company says it will be quicker and easier, but it stands to slow the adoption of cheaper competitors and increase costs by billions of dollars.
from NYT > Health https://ift.tt/n30ZYBx
Check out
Subscribe to:
Post Comments (Atom)
New Treatment Lets 3 Transplant Patients Halt Anti-Rejection Drugs
Researchers at the University of Pittsburgh gave transplant recipients certain immune cells from their organ donors. It didn’t always work. ...
-
Low density lipoprotein or simply known as cholesterol is dangerous to the heart and can lead to heart attack and stroke, but the good thing...
-
A long stay in intensive care can bring physical, cognitive and mental health challenges that can take months or longer to resolve. from N...
-
Captive animals sometimes need a transfusion, but the typical approach to blood banking isn’t practical for zoos and aquariums. One veterina...
No comments:
Post a Comment